COGNEX CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $994.4M | $914.5M | $837.5M | $1.0B | $1.0B |
| Cost of revenue | $329.0M | $288.7M | $236.3M | $284.2M | $277.3M |
| Gross profit | $665.4M | $625.8M | $601.2M | $721.9M | $759.8M |
| Selling, general & administrative | $363.9M | $370.9M | $339.1M | $312.1M | $309.4M |
| Research and development | $139.0M | $139.8M | $139.4M | $141.1M | $135.4M |
| Operating income | $162.6M | $115.1M | $130.7M | $246.2M | $315.1M |
| Pretax income | $182.8M | $131.5M | $135.3M | $250.7M | $318.9M |
| Income tax expense | $68.4M | $25.3M | $22.1M | $35.2M | $39.0M |
| Net income | $114.4M | $106.2M | $113.2M | $215.5M | $279.9M |
| Balance Sheet | |||||
| Cash and equivalents | $262.9M | $186.1M | $202.7M | $181.4M | $186.2M |
| Current assets | $697.2M | $613.4M | $679.0M | $717.7M | $639.8M |
| Total assets | $2.0B | $2.0B | $2.0B | $2.0B | $2.0B |
| Current liabilities | $183.6M | $169.4M | $151.9M | $187.7M | $188.6M |
| Total liabilities | $524.7M | $475.3M | $513.1M | $519.7M | $573.6M |
| Stockholders' equity | $1.5B | $1.5B | $1.5B | $1.4B | $1.4B |
| Cash Flow Statement | |||||
| Cash from operations | $245.5M | $149.1M | $112.9M | $243.4M | $314.1M |
| Depreciation and amortization | $20.3M | $21.3M | $17.3M | $16.3M | $16.6M |
| Stock-based compensation | $48.5M | $52.4M | $54.8M | $54.5M | $43.8M |
| Capital expenditure | $8.7M | $15.0M | $23.1M | $19.7M | $15.5M |
| Free cash flow | $236.8M | $134.0M | $89.8M | $223.7M | $298.6M |
| Dividends paid | $54.6M | $52.3M | $49.1M | $45.9M | $43.3M |
| Share repurchases | $151.2M | $67.1M | $79.8M | $204.3M | $161.7M |
Shares outstanding 166.4M · Free float 98.2%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.